换一批
换一批Rationale, Design, and Baseline Characteristics of the Utopia Trial for Preventing Diabetic Atherosclerosis Using an SGLT2 Inhibitor: A Prospective, Randomized, Open-Label, Parallel-Group Comparative Study.
作者：
Naoto,Katakami [1]
;
Tomoya,Mita [2]
;
Hidenori,Yoshii [3]
;
Toshihiko,Shiraiwa [4]
;
Tetsuyuki,Yasuda [5]
;
Yosuke,Okada [6]
;
Yutaka,Umayahara [7]
;
Hideaki,Kaneto [8]
;
Takeshi,Osonoi [9]
;
Tsunehiko,Yamamoto [10]
;
Nobuichi,Kuribayashi [11]
;
Kazuhisa,Maeda [12]
;
Hiroki,Yokoyama [13]
;
Keisuke,Kosugi [14]
;
Kentaro,Ohtoshi [15]
;
Isao,Hayashi [16]
;
Satoru,Sumitani [17]
;
Mamiko,Tsugawa [18]
;
Makoto,Ohashi [19]
;
Hideki,Taki [20]
;
Tadashi,Nakamura [21]
;
Satoshi,Kawashima [22]
;
Yasunori,Sato [23]
;
Hirotaka,Watada [24]
;
Iichiro,Shimomura [3]
;
UTOPIA study investigators [25]
作者单位：
Department of Metabolic Medicine, Osaka University Graduate School of Medicine, 2-2, Yamadaoka, Suita, Osaka, 565-0871, Japan. katakami@endmet.med.osaka-u.ac.jp.
[1]
Department of Metabolism and Atherosclerosis, Osaka University Graduate School of Medicine, 2-2, Yamadaoka, Suita, Osaka, 565-0871, Japan. katakami@endmet.med.osaka-u.ac.jp.
[2]
Department of Metabolism and Endocrinology, Juntendo University Graduate School of Medicine, Hongo 2-1-1, Bunkyo-ku, Tokyo, 113-8421, Japan.
[3]
Department of Medicine, Diabetology and Endocrinology, Juntendo Tokyo Koto Geriatric Medical Center, Koto-ku, Tokyo, 136-0075, Japan.
[4]
Shiraiwa Medical Clinic, 4-10-24 Hozenji, Kashiwara City, Osaka, 582-0005, Japan.
[5]
Department of Endocrinology and Metabolism, Osaka Police Hospital, 10-31, Kitayama-cho, Tennoji-ku, Osaka, 543-0035, Japan.
[6]
First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Japan, 1-1, Iseigaoka, Yahatanishi-ku, Kitakyushu, 807-8555, Japan.
[7]
Department of Diabetes and Endocrinology, Osaka General Medical Center, 3-1-56, Bandai-Higashi, Sumiyoshi-ku, Osaka, 558-8558, Japan.
[8]
Department of Diabetes, Endocrinology and Metabolism, Kawasaki Medical School, 577 Matsushima, Kurashiki, Okayama, 701-0192, Japan.
[9]
Nakakinen Clinic, 745-5, Nakadai, Naka City, Ibaraki, 311-0113, Japan.
[10]
Diabetes and Endocrinology, Kansai Rosai Hospital, 3-1-69, Inabaso, Amagasaki city, Hyogo, Japan.
[11]
Misaki Naika Clinic, 6-44-9, Futawa-higashi, Funabashi City, Chiba, Japan.
[12]
Kitasenri Maeda Clinic, 4-119, Furuedai, Suita, Osaka, 565-0874, Japan.
[13]
Jiyugaoka Medical Clinic, West 6, South 6-4-3, Obihiro, Hokkaido, 080-0016, Japan.
[14]
Kosugi Medical Clinic, 3-9, Tamatsukurimoto-cho, Tennoji-ku, Osaka, 543-0014, Japan.
[15]
Otoshi Medical Clinic, 8-47, Kakudacho, Osaka Kita-ku, Osaka, 530-0017, Japan.
[16]
Hayashi Clinic, 3-9-23 Koshienguchi, Nishinomiya, Hyogo, 663-8113, Japan.
[17]
Center for Diabetes and Endocrinology, Nissay Hospital, 6-3-8, Itachibori, Nishi-ku, Osaka, 550-0012, Japan.
[18]
Department of Endocrinology and Metabolism, Ikeda Municipal Hospital, 3-1-18, Jonan, Ikeda, Osaka, 563-8510, Japan.
[19]
Center for Diabetes Mellitus, Osaka Rosai Hospital, 1179-3 Nagasone-cho, Kita-ku, Sakai, Osaka, 591-8025, Japan.
[20]
Diabetes Center, National Hospital Organization Osaka National Hospital, 2-1-14, Hoenzaka, Chuo-ku, Osaka, 540-0006, Japan.
[21]
Department of Internal Medicine, Kawasaki Hospital, 3-3-1, Higashiyamacho, Kobe Hyogo-ku, Hyogo, 652-0042, Japan.
[22]
Kanda Naika Clinic, 5-21-3, Hannancho, Osaka Abeno-ku, Osaka, 545-0021, Japan.
[23]
Department of Global Clinical Research, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba, 260-8677, Japan.
[24]
Department of Metabolic Medicine, Osaka University Graduate School of Medicine, 2-2, Yamadaoka, Suita, Osaka, 565-0871, Japan.
[25]
DOI
10.1007/s13300-017-0292-1
PMID
28864997
发布时间
2020-09-29
- 浏览22
Diabetes therapy
Diabetes therapy
999-1013页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
